Relationship of pregnancy-associated plasma protein-A to renal function and dialysis modalities

Kidney and Blood Pressure Research

Volumn 27, Issue 2, 2004, Pages 88-95

  Fialova L ^a   Kalousova M ^a   Soukupova J ^a   Sulkova S ^a   Merta, M ^a   Jelinkova E ^a   Horejsi M ^a   Sramek P ^b   Malbohan, I ^a   Mikulikova L ^a   Tesar V ^a   Zima, T ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b Pharmacon Research   (Czech Republic)

Author keywords

Advanced oxidation protein products; Hemodialysis; Pregnancy associated plasma protein A; Renal failure

Indexed keywords

PLASMA PROTEIN; PREGNANCY ASSOCIATED PROTEIN;

ADULT; AGED; ARTICLE; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE CLEARANCE; DIALYSIS; DISEASE MARKER; HEMODIALYSIS; HUMAN; INFLAMMATION; KIDNEY FAILURE; KIDNEY FUNCTION; MEASUREMENT; OXIDATIVE STRESS; PREGNANCY; PRIORITY JOURNAL; PROTEIN URINE LEVEL; SPECTROPHOTOMETRY; STATISTICAL SIGNIFICANCE;

AGED; BIOLOGICAL MARKERS; BLOOD PROTEINS; C-REACTIVE PROTEIN; FEMALE; HUMANS; INFLAMMATION; KIDNEY; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; OXIDATIVE STRESS; PERITONEAL DIALYSIS, CONTINUOUS AMBULATORY; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A; RENAL DIALYSIS; SEVERITY OF ILLNESS INDEX;

EID: 2342475710     PISSN: 14204096     EISSN: None     Source Type: Journal    
DOI: 10.1159/000076390     Document Type: Article

References (38)

1. Witko-Sarsat V, Friedlander M, Capeillère-Blandin Ch, Nguyen-Khoa T, Nguyen A T, Zingraff J, Jungers P, Descamps-Latscha B: Advanced oxidation protein products as a novel marker of oxidative stress in ureamia. Kidney Int 1996;49:1304-1313.
2. Kalousová M, Zima T, Tesař V, Sulková S, Fialová L: Relationship between advanced glycoxidation end products, inflammatory markers/acute phase reactants and some autoantibodies in chronic hemodialysis patients. Kidney Int Suppl 2003;63(suppl 84):S62-S64.
3. Kalousová M, Sulková S, Fialová L, Soukupová J, Malbohan IM, Špaček P, Braun M, Mikulíková L, Fořtová M, Hořejší M, Tesař V, Zima T: Glycoxidation and inflammation in chronic hemodialysis patients. Nephrol Dial Transplant 2003;18:2577-2581.
4. Miyata T, Ypersele de Strihou C, Kurokawa K, Baynes JW: Alterations in nonenzymatic biochemistry in uremia: Origin and significance of 'carbonyl stress' in long-term uremic complications. Kidney Int 1999;55:389-399.
5. Schwedler S, Schinzel R, Vaith P, Wanner C: Inflammation and advanced glycation end products in uremia: Simple coexistence, potentiation or causal relationship? Kidney Int 2001;59(suppl. 78):S32-S36.
6. Zimmermann J, Herrlinger S, Pruy A, Metzger T, Wanner C: Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int 1999;55:648-658.
7. Cristol JP, Canaud B, Rabesandratana H, Gaillard I, Serre A, Mion C: Enhancement of reactive oxygen species production and cell surface markers expression due to haemodialysis. Nephrol Dial Transplant 1994;9:389-394.
8. Stocker W, Grams F, Baumann U, Reinemer P, Gomis-Ruth FX, McKay DB, Bode W: The metzincins-topological and sequential relations between the astacins, adamalysins, serralysins, and matrixins (collagenases) define a superfamily of zinc-peptidases. Protein Sci 1995;4:823-840.
9. Welgus HG, Campbell EJ, Cury JD, Eisen AZ, Senior RM, Wilhelm SM, Goldberg GI: Neutral metalloproteinases produced by human mononuclear phagocytes: Enzyme profile, regulation, and expression during cellular development. J Clin Invest 1990;86:1496-1502.
10. Creemers E, Cleutjens J, Smits J, Daemen M: Matrix metalloproteinase inhibition after myocardial infarction: A new approach to prevent heart failure? Circ Res 2001;89:201-210.
11. Partridge CA, Jeffrey JJ, Malík AB: A 96-kD gelatinase induced by TNF-alpha contributes to increased microvascular endothelial permeability. Am J Physiol 1993;265:L438-L447.
12. Ebihara I, Nakamura T, Tomino Y, Shimada N, Koide H: Metalloproteinase-9 mRNA expression in monocytes from patients with chronic renal failure. Am J Neprol 1998;18:305-310.
13. McMillan JI, Riordan JW, Couser WG, Pollock AS, Lovett DH: Characterization of a glomerular epithelial cell metalloproteinase as matrix metalloproteinase-9 with enhanced expression in a model of membranous nephropathy. J Clin Invest 1996;97:1094-1101.
14. Libby P: What have we learned about the biology of atheroslerosis? The role of inflammation. Am J Cardiol 2001;88(suppl):3J-6J.
15. Galis ZS, Sukhova GK, Lark MW, Libby P: Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest 1994;94:2493-2503.
16. Foley RN, Parfrey PS, Harnett JD, Kent GM, Martin CJ, Murray DC, Barre PE: Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. Kidney Int 1995;47:186-192.
17. Boldt HB, Overgaard MT, Laursen LS, Weyer K, Sottrup-Jensen L, Oxvig C: Mutational analysis of the proteolytic domain of pregnancyassociated plasma protein-A (PAPP-A): Classification as a metzincin. Biochem J 2001;358:359-367.
18. Lawrence JB, Oxvig C, Overgaard MT, Sottrup-Jensen L, Gleich GJ, Hays LG, Yates JR, Conover ChA: The insulin-like growth factor (IGF)-dependent IGF binding protein-4 protease secreted by human fibroblasts is pregnancy-associated plasma protein-A. Proc Natl Acad Sci USA 1999;96:3149-3153.
19. Lin TM, Halbert SP, Kiefer D, Spellacy WN, Gall S: Characterization of four pregnancy-associated plasma proteins. Am J Obstet Gynecol 1974;118:223-236.
20. Bayes-Genis A, Conover ChA, Overgaard MT, Bailey KR, Christiansen M, Holmes DR, Virmani, R, Oxvig C, Schwartz RS: Pregnancy-associated plasma protein A as a marker of acute coronary syndromes. N Engl J Med 2001;345:1022-1029.
21. Overgaard MT, Haaning J, Boldt HB, Olsen IM, Laursen LS, Christiansen M, Gleich GJ, Sottrup-Jensen L, Conover ChA, Oxvig C: Expression of recombinant human pregnancy-associated plasma protein-A and identification of the proform of eosinophil major basic protein as its physiological inhibitor. J Biol Chem 2000;275:31128-31133.
22. Kristensen T, Oxvig C, Sand O, Moller NP, Sottrup-Jensen L: Amino acid sequence of human pregnancy-associated plasma protein-A derived from cloned cDNA. Biochemistry 1994;33:1592-1598.
23. Oxvig C, Sand O, Kristensen T, Gleich GJ, Sottrup-Jensen L: Circulating human pregnancy-associated plasma protein-A is disulfide-bridged to the proform of eosinophil major basic protein. J Biol Chem 1993;268:12243-12246.
24. Sinosich MJ: Pregnancy-associated plasma protein A: Fact, fiction and future; in Chapman M, Grudzinskas G, Chard T (eds): Implantation - Biological and Clinical Aspects. London, Springer, 1988, pp 45-81.
25. Bode W, Gomis-Ruth FX, Stockler W: Astacins, serralysins, snake venom and matrix metalloproteinases exhibit zinc-binding environments and topologies and should be grouped into a common family, the 'metzins'. FEBS Lett 1993;331:134-140.
26. Laursen LS, Overgaard MT, Soe R, Boldt BH, Sottrup-Jensen L, Giudice LC, Conover ChA, Oxvig C: Pregnancy-associated plasma protein A (PAPP-A) cleaves insulin-like growth factor binding protein (IGFBP)-5 independent of IGF: Implications for the mechanism of IGFBP-4 proteolysis by PAPP-A. FEBS Lett 2001;504:36-40.
27. Brambati B, Macintosh MCM, Teisner B, Maguiness S, Shrimanker K, Lanzani A, Bonacchi L, Tului L, Chard T, Grudzinskas JG: Low maternal serum levels of pregnancy associated plasma protein A (PAPP-A) in the first trimester in association with abnormal fetal karyotype. Br J Obstet Gynaecol 1993;100:324-326.
28. Wald NJ, George L, Smith D, Densem JW, Petterson K: Serum screening for Down's syndrome between 8 and 14 weeks of pregnancy. Br J Obstet Gynaecol 1996;103:407-412.
29. Qin QP, Nguyen TH, Christiansen M, Larsen SO, Norgaard-Pedersen B: Time-resolved immunofluorometric assay of pregnancy-associated plasma protein A in maternal serum screening for Down's syndrome in first trimester of pregnancy. Clin Chim Acta 1996;254:113-129.
30. Overgaard MT, Oxvig C, Christiansen M, Lawrence JB, Conover ChA, Gleich GJ, Sottrup-Jensen L, Haaning J: Messenger ribonucleic acid levels of pregnancy-associated plasma protein-A and the proform of eosinophil major basic protein: Expression in human reproductive and nonreproductive tissues. Biol Reprod 1999;61:1083-1089.
31. Schindler AM, Bischof P: Histochemical localization of pregnancy-associated plasma protein A in fetal, infant and adult organs and comparison between antisera. Gynecol Obstet Invest 1984;18:88-94.
32. Descamps-Latscha B, Witko-Sarsat V: Importance of oxidatively modified proteins in chronic renal failure. Kidney Int 2001;59(suppl 78):S108-S113.
33. Kalousová M, Zima T, Tesař V, Lachmanová J: Advanced glycation end products and advanced oxidation protein products in hemodialyzed patients. Blood Purification, 2002;20:531-536.
34. Miyata T, Sugiyama S, Saito A, Kurokawa K: Reactive carbonyl compounds related uremic toxicity ('carbonyl stress'). Kidney Int 2001;59(suppl 78):S25-31.
35. Ebihara I, Nakamura T, Shimada N, Koide H: Increased plasma metalloproteinase-9 concentrations precede development of microalbuminuria in non-insulin-dependent diabetes mellitus. Am J Kidney Dis 1998;32:544-550.
36. Hafner G, Thome-Kromer B, Schaube J, Kupferwasser I, Ehrenthal W, Cummins P, Prellwitz W, Michel G: Cardiac troponins in serum in chronic renal failure (letter). Clin Chem 1994;40:1790-1791.
37. Li D, Keffer J, Corry K, Vazquez M, Jialal I: Nonspecific elevations of troponin T levels in patients with chronic renal failure. Clin Biochem 1995;28:474-477.
38. Baum H, Obst M, Huber U, Neumeier D: Cardiac troponin T in patients with high creatinine concentration but normal creatine kinase activity in serum. Clin Chem 1996;42:474-475.